Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicinal composition and its use in preparing medicine for treating or preventing cardio-cerebral vascular diseases

A composition and drug technology, applied in cardiovascular system diseases, drug combination, drug delivery, etc., can solve the problem of unreported synergy

Inactive Publication Date: 2006-03-22
SHANDONG GREENERY NATURAL MEDICINE RES & DEV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Although magnolol or its salts, honokiol or its salts have a certain protective effect on cardiovascular and cerebrovascular diseases, the pharmaceutical composition of magnolol or its salts and honokiol or its salts is effective in preventing Or there is no report of synergistic effect in the treatment of cardiovascular and cerebrovascular diseases. The inventor has invented a kind of pharmaceutical composition composed of magnolol or its salt and honokiol or its salt through a large amount of experimental research, and its use in Use in prevention or treatment of cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition and its use in preparing medicine for treating or preventing cardio-cerebral vascular diseases
  • Medicinal composition and its use in preparing medicine for treating or preventing cardio-cerebral vascular diseases

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0020] Preparation example 1: preparation of magnolol and its magnesium salt, sodium salt; honokiol and its magnesium salt, sodium salt

[0021] According to the literature [Zhang Zhongyi, Huang Changquan, Lei Zhengjie, et al. Supercritical CO 2 Research on extracting magnolol. Guangdong Pharmacy, 1999, 9(3): 20.] Prepared by the method described.

[0022] After 12.5kg of magnolia bark is pulverized, put it into the extraction kettle, heat the extraction kettle, the analysis kettle I, and the analysis kettle II respectively, and when the temperature reaches 35°C, 40°C, and 37°C, the extraction kettle, the two The analysis kettle was pressurized, and when the pressure reached 22mPa, 7.5mPa and 6mPa respectively, the circular extraction was started, and the constant temperature and pressure were kept, and each cycle was 10min, and the materials were discharged from the analysis kettle I and III to obtain 605g of a light yellow extract. for 4h. Dissolve Magnolia officinalis ext...

preparation example 2

[0027] Preparation example 2: Preparation of a freeze-dried powder injection with magnolol magnesium salt and honokiol magnesium salt as active ingredients

[0028] Under clean conditions, take 30g of magnolol magnesium salt and 60g of honokiol magnesium salt, dissolve them in 1000ml of water for injection, add 100g of mannitol, stir to dissolve, and ultrafilter to obtain a pyrogen-free clear solution, press lyophilized powder for injection The process is freeze-dried to make a freeze-dried powder injection containing 30 mg of magnesium salt of magnolol and 60 mg of magnesium salt of honokiol.

[0029] Under clean conditions, take 18g of magnolol magnesium salt and 72g of honokiol magnesium salt, dissolve them in 1000ml of water for injection, add 100g of mannitol, stir to dissolve, and ultrafilter to obtain a pyrogen-free clear solution, press the freeze-dried powder injection The process is freeze-dried to make a freeze-dried powder injection containing 18 mg of magnolol mag...

preparation example 3

[0030] Preparation Example 3: Preparation of a freeze-dried powder injection with magnolol sodium salt and honokiol sodium salt as active ingredients

[0031] Under clean conditions, take 60g of magnolol sodium salt and 30g of honokiol sodium salt, add polyoxyethylene glycerol triricinoleate-3L (EL-35) 180ml, dissolve in 1000ml of water for injection, add and stir to dissolve, Ultrafiltration was obtained to obtain a pyrogen-free clear liquid, which was freeze-dried according to the freeze-dried powder injection process to make a freeze-dried powder injection containing 60 mg of magnolol sodium salt and 30 mg of honokiol sodium salt.

[0032]Under clean conditions, take 72g of magnolol sodium salt and 18g of honokiol sodium salt, add polyoxyethylene glycerol triricinoleate-3L (EL-35) 180ml, dissolve in 1000ml of water for injection, add and stir to dissolve, Ultrafiltration was obtained to obtain a pyrogen-free clear solution, which was freeze-dried according to the freeze-dri...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides magnolol, magnolol salt and their medicine composition, and their application in treating and preventing cardiac and cerebral vascular diseases. The medicine composition has effect in treating and preventing cardiac and cerebral vascular diseases far higher than that of magnolol and / or magnolol salt.

Description

technical field [0001] The invention relates to a pharmaceutical composition, which is composed of magnolol or its salt and honokiol or its salt, and also relates to the application of the pharmaceutical composition in the preparation of medicines for treating or preventing cardiovascular and cerebrovascular diseases. Background technique [0002] Magnolol and honokiol are active ingredients extracted from Magnolia officinalis. The structural formulas of magnolol and honokiol are as follows: [0003] [0004] Magnolol structure [0005] [0006] Honokiol structure [0007] Several documents have reported the pharmacological effects of magnolol, magnolol salts, honokiol, and honokiol salts on the prevention and treatment of cardiovascular and cerebrovascular diseases. [0008] Zhang Guangqin and others studied that magnolol has protective effect on cerebral ischemia [Zhang Guangqin, Chen Shizhong, Hao Xuemei, et al. The protective effect of magnolol on cerebral ische...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/05A61K9/00A61P9/10
Inventor 蒋王林孙芳张太平田京伟
Owner SHANDONG GREENERY NATURAL MEDICINE RES & DEV